Novavax, Inc (NASDAQ:NVAX) concluded the trading at $8.63 on Wednesday, December 18, with a fall of -4.11% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $9.00 and 5Y monthly beta was
Novavax, Inc (NASDAQ:NVAX) traded at $9.29 at last check on current trade day and made an upward move of 1.99% on its previous day’s price. Looking at the stock we see that its previous close was $9.11 and the beta (5Y monthly) reads 2.088 with
Novavax, Inc (NASDAQ:NVAX) shares, rose in value on Thursday, December 12, with the stock price up by 2.27% to the previous day’s close as strong demand from buyers drove the stock to $9.02. Actively observing the price movement in the last trading, the stock closed
Shares of US biotech company Novavax at the August 5 aftermarket trading rose 5%, then plunged more than 17% to $204.76 each. The plunge was in response to the upcoming transfer of the application to the United States Food and Drug Administration (FDA) for approval
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
